266 related articles for article (PubMed ID: 21046407)
1. TDP-43 plasma levels do not differentiate sporadic inclusion body myositis from other inflammatory myopathies.
Kuiperij HB; Abdo WF; van Engelen BG; Schelhaas HJ; Verbeek MM
Acta Neuropathol; 2010 Dec; 120(6):825-6. PubMed ID: 21046407
[No Abstract] [Full Text] [Related]
2. Inflammatory Myopathies: Utility of Antibody Testing.
Biliciler S; Kwan J
Neurol Clin; 2020 Aug; 38(3):661-678. PubMed ID: 32703475
[TBL] [Abstract][Full Text] [Related]
3. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
Hiniker A; Daniels BH; Lee HS; Margeta M
Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466
[TBL] [Abstract][Full Text] [Related]
4. A surprising case of inclusion body myositis with positive endomysial C5b-9 staining.
Buchman S; Bandyopadhyay S; Baccon J; Wicklund M
Muscle Nerve; 2016 Jun; 53(6):991-2. PubMed ID: 26659413
[No Abstract] [Full Text] [Related]
5. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
6. [Idiopathic myositis].
Burgunder JM
Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
[TBL] [Abstract][Full Text] [Related]
7. Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.
Needham M; Mastaglia FL
Clin Neurophysiol; 2016 Mar; 127(3):1764-73. PubMed ID: 26778717
[TBL] [Abstract][Full Text] [Related]
8. Sporadic inclusion body myositis misdiagnosed as idiopathic granulomatous myositis.
Lavian M; Goyal N; Mozaffar T
Neuromuscul Disord; 2016 Nov; 26(11):741-743. PubMed ID: 27692540
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of inclusion body myositis.
Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and classification of sporadic inclusion body myositis (sIBM).
Catalán M; Selva-O'Callaghan A; Grau JM
Autoimmun Rev; 2014; 13(4-5):363-6. PubMed ID: 24424185
[TBL] [Abstract][Full Text] [Related]
11. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
12. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.
Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE
Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790
[TBL] [Abstract][Full Text] [Related]
13. Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis.
Larue S; Maisonobe T; Benveniste O; Chapelon-Abric C; Lidove O; Papo T; Eymard B; Dubourg O
J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):674-7. PubMed ID: 20562458
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
15. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
[TBL] [Abstract][Full Text] [Related]
16. Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations.
Hou Y; Luo YB; Dai T; Shao K; Li W; Zhao Y; Lu JQ; Yan C
J Neuropathol Exp Neurol; 2018 May; 77(5):395-404. PubMed ID: 29522204
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
18. Unicorns, dragons, polymyositis, and other mythical beasts.
Askanas V; Engel WK
Neurology; 2004 Jul; 63(2):403-4; author reply 404. PubMed ID: 15277658
[No Abstract] [Full Text] [Related]
19. Polymyositis: not a unicorn or mythological beast...but maybe a duck?
Kissel JT
Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286
[No Abstract] [Full Text] [Related]
20. Cytosolic 5'-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis.
Lilleker JB; Rietveld A; Pye SR; Mariampillai K; Benveniste O; Peeters MT; Miller JA; Hanna MG; Machado PM; Parton MJ; Gheorghe KR; Badrising UA; Lundberg IE; Sacconi S; Herbert MK; McHugh NJ; Lecky BR; Brierley C; Hilton-Jones D; Lamb JA; Roberts ME; Cooper RG; Saris CG; Pruijn GJ; Chinoy H; van Engelen BG;
Ann Rheum Dis; 2017 May; 76(5):862-868. PubMed ID: 28122761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
